CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT04609241 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04609241
- Sponsor
- Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-15
- Primary completion
- 2023-11-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.